Skip to main content
TipRanks
Go Ultimate75% OFF

BioCryst (BO1) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

BO1 Analyst Ratings

Moderate Buy
6Ratings
4Buy2Hold0Sell
Based on 6 analysts giving stock ratings to BioCryst in the past 3 months

BO1 Stock 12 Month Forecast

€15.37▲(123.68% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for BioCryst in the last 3 months. The average price target is EUR 15.37 with a high forecast of EUR 27.12 and a low forecast of EUR 9.94. The average price target represents a 123.68% change from the last price of EUR 6.87.
Highest Price Target€27.12Average Price Target€15.37Lowest Price Target€9.94

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:BO1
Price TargetArticle
Wedbush€18.08→€15.37buy123.68%UpsideReiterated11/05/26
RBC Capital€9.94hold44.73%UpsideReiterated11/04/26
TD Cowen€27.12buy294.73%UpsideReiterated10/21/26
Bank of America Securities€13.56buy97.36%UpsideReiterated10/09/26
J.P. Morgan€10.85→€11.75hold71.05%UpsideAssigned09/30/26
Needham€14.46buy110.52%UpsideReiterated09/08/26
Evercore ISI Analyst forecast on DE:BO1Unknown AnalystNot RankedEvercore ISI€15.37buy123.68%UpsideReiterated08/10/26
H.C. Wainwright€28.93buy321.04%UpsideReiterated08/06/26
Cantor Fitzgerald€24.41→€26.21buy281.57%UpsideReiterated06/30/26
Citizens JMP€22.60→€25.31buy268.41%UpsideReiterated05/07/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioCryst

3 Months
Tazeen Ahmad
Tazeen AhmadBank of America Securities
Success Rate8/18 ratings generated profit
44%
Average Return
-0.27%

Copying Tazeen Ahmad's trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of -0.27% per trade.

1 Year
Tazeen Ahmad
Tazeen AhmadBank of America Securities
Success Rate10/18 ratings generated profit
56%
Average Return
+3.58%

Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +3.58% per trade.

2 Years
Success Rate13/25 ratings generated profit
52%
Average Return
+6.95%

Copying Serge Belanger's trades and holding each position for 2 Years would result in 52.00% of your transactions generating a profit, with an average return of +6.95% per trade.

BO1 Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for BO1
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy1212984
Buy22210
Hold11334
Sell00000
Strong Sell00000
total151514128

In the current month, BO1 has received 4 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. BO1 average Analyst price target in the past 3 months is 15.37.

BO1 Financial Forecast

€-4€-2.5€-1€0.5€2Q1 2026Q3 2026Q4 2026
High€0.14
Consensus€0.08
Low€0.00

BO1 Earnings Forecast

Next quarter’s earnings estimate for BO1 is EUR 0.08 with a range of EUR 0.00 to EUR 0.14. The previous quarter’s EPS was EUR 0.13. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€141.4M€197.9M€254.4M€311M€367.5MQ1 2026Q3 2026Q4 2026
High€156M
Consensus€149M
Low€144M

BO1 Sales Forecast

Next quarter’s sales forecast for BO1 is EUR 149.37M with a range of EUR 143.83M to EUR 156.27M. The previous quarter’s sales results were EUR 162.97M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

BO1 Stock Forecast FAQ

What is DE:BO1’s average 12-month price target, according to analysts?
Based on analyst ratings, BioCryst’s 12-month average price target is €15.37.
What is DE:BO1’s upside potential, based on the analysts’ average price target?
BioCryst has 123.68% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BioCryst a Buy, Sell or Hold?
BioCryst has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 2 hold ratings and 0 sell ratings.
What is BioCryst’s share price target?
The average share price target for BioCryst is €15.37. This is based on 6 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €27.12, and the lowest forecast is €9.94. The average share price target represents a 123.68% increase from the current price of €6.87.
What do analysts say about BioCryst?
BioCryst’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Street analysts.
How can I buy shares of BioCryst?
To buy shares of DE:BO1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.